原田篤実(Atsumi Harada, MD,PhD)

 

1)    Kato N, Harada A, Iida H, Onoyama K, Fujimi S, Uzawa H, Omae T: Studies on three cases of idiopathic membranous glomerulonephropathy associated with diabetes mellitus. Kumamoto Med J 31:110-119,1978

2)    Iseki K, Onoyama K, Meda T, Simamatsu K, Harada A, Fujimi S, Omae T: Comparison on hemodynamics by conventional acetate hemodialysis,bicarbonate hemodialysis and ultrafiltration. Clin Nephrol 14:294-298,1980

3)    Shimamatsu K,Maeda T,Harada A,Nisitani H,Onoyama K,Fujimi S,Omae T: 1-year controlled trial of 1αhydroxycholecalciferol in patients on maintenance hemodialysis. Nephron 28:70-75,1981

4)    Kobayashi K,Harada A,Onoyama K,Shimamatsu K.Maeda T,Fujimi S,Omae T:Idiopathic membranous glomerulonephritis associated with diabetes mellitus.  Nephron 28:163-168,1981

5)    Harada A,Tomita Y,Yamamoto H,Onoyama K,Omae T,Oh Y,Kimura T.: Renal amyoidoasis associated with crescentic glomerulonephritis. Am J Nephrol 4:52-55,1984

6)    Simamatsu K,Onoyama K,Harada A.Kumagai H,Hirakata H,Miishima C,Inenaga T,Fujimi S,Omae T: Effect of blood pressure on the progression of renal impairment in chronic glomerulonephritis. J Clin Hypertens 3:239-244,1985

7)    Kumagai H.Onoyama K.Washio M,Harada A,Takenaka M,Kobayasi M,Takeyosi S: A case of neuroleptic malignant syndrome with acute renal failure effectively treated with dantrolene. Cur Ther Res 42:889-894,1987

8)    Kumagai H,Inenaga T,Shimamatsu K,Nakamoto M,Fujimi S,Harada A,Onoyama K: A csse of acute poststreptococcal glomerulonephritis associated with cerebral hemorrhage. J J neprol 29:83-87,1987

9)    Harada A,Inenaga T,Washio M: Pharmacokinetics of ramipril in chronic renal failure. Cur Ther Res 44:200-212,1988

10)  Shouno Y,Shimokawa T,Sakemi T,Harada A,Yamaguci M,Watanabe T: Segmental glomerular necrosis as an active index of IgA nephropathy: A study with 100 serial sections of 128 cases. Acta Pathol Jap 43:723-729,1993

11)  Tsuruya K,Harada A.Kubo S,Mitsuiki K,Takeda K: Cibenzoline-induced respiratory muscular paralysis in a hemodialysis patient. Clin Exper Nephrol 1:131-135,1997

12)  Takeda K,Harada A,Hirakata H,Fujimi S,Oh Y,Fujishima M: Three-year outcome after urinary diversions in patients with obstructive uropaty. Nephron 78:246-248,1998

13)  Takeda K,Harada A.Kubo M,Inenaga T,Tsuruya K,Mitsuiki K,Hirakata H,Fujishima M. Successful use of single-lumen,urokinase immobilized femoral cateters as a temporary access for haemodialysis. Nephron 13:130-133,1998

14)  Tsuruya K,Harada A,Hirakata H,Mitsuiki K,Johko T,Kondoh H,Takechi S,Fujishima M: Combination  therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropaty. Clin Nephrol 53::1-9,2000

15)  Mitsuiki K,Harada A,Miyata Y: Reduction of recombinant human erythropoietin maintenance dose by supplementation with a low-dose iron preparation Clin Exp Nephrol 5:228-233.2001

16)  Nagata M,Simokama T,Harada A,Koyama A,Watanabe T: Glomerular crescents in renal amyloidosis:An epiphenomenon or distinct pathology? Pathol Int51:179-186,2001

17)  Mitsuiki K,Harada A,Miyata Y: Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content. Clin Exp Nephrol 7:52-57,2003

18)  Sanai T,Okuda S,Yoshimitsu T,Oochi N,Kumagai H,Katafuchi R,Harada A, Chihara J,Abe T,Nakamoto M,Hirakata H,Onoyama K,Iida M: Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus. Nephrology 12:69-73,2007

19)  Mitsuiki K,Harada A,Miyata Y: Reticulocyte hemoglobin content in hemodialysis patients with acute infection. Clin Exp Nephrol 8:257-262,2004

20)  Mitsuiki K,Harada A,Okura T,Higaki J: Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclopospamide. Clin Exp Nephrol 11:297-303,2007

21)  Suzuki T,Horita S,Kadoya K,Mitsuiki K,,Aita K.Harada A,Nitta K,Nagata M. C4d Immunohistochemistry in glomerulonephritis with different antibodies. Clin Exp Nephrol 11:287-291,2007

22)  Eriguchi M,Nagao,T,Kamimura T,Sugawara K,Mitsuiki K,Harada A: Pulmonary capillary embolism caused by cryptococcemia in a hemodialysis patient. Clin Nephrol 70:1-4,2008

23)  Eriguchi M,Oka H.Mizobuchi T,Kamimura T,Sugawara K,Harada A: Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. Nephrol Dial Transplant 24:3082-3088,2009

24)  Hara M,Yamada S,Nakamura Y,Oka H,Kamimura T,Nakane S,Tsuruya K,Harada A:Autoimmune autonomic ganglionopathy manifesting as acute-onset orthostatic hypotension in a patient undergoing peritoneal dialysis. CEN Case Rep 5:5-10,2016

25)  Oka H,Yamada S,Kamimura T,Hara M,Hirasima Y,Matsueda S,Shukuri T,Aihara S,Koresawa M,Eriguci M,Harada A.Tsuruya K,Kitazono T: Modified simple peritoneal wall anchor technique(PWAT) in peritoneal dialysis. Perit Dial Int 37:102-108,2017

26)  Oka H,Kamimura T,Hiramatsu Y,Fukumitsu K.Iwata R,Kondo M,Hirashima Y,Aihara S,Harada A,Tsuruya K: Cholesterol crystal embolism induced by direct factor Xa inhibitor: A first case report. Inter Med 57:71-74,2018

27)  Aihara S,Yamada S,Matsusaka H,Tashiro R,Oka H,Kamimura T,Harada A,Nakano T,Kitazono T,Tsuruya K: A case of congenital left ventricular diverticulum in a patient with autosomal dominant polycystic kidney disease: possible mechanism link between polycystin and ventricular diverticulum. CEN Case Report 7:237-242,2018

28)  Oka H.Yamada S,Kamimura T,Harada A,Tsuruya K,Nakano T,Kitazono T: Early postoperative change in serum creatinine predict acute kidney injury after cardiothoracic surgery: a retrospective cohort study. Clin Exp Nephrol 23:325-334,2019

29)  Oka H,Yamada S,Kamimura T,Aihara S,Hyodo M,Terakado N,Harada A,Nakano T,Tsuruya K,Kitazono T: Better oral hygiene habits are associated with a lower incidence of peritonealdialysis-related peritonitis. Ther Apher Dial 28:187-194,2019

30)  Aihara S, Yamada S, Oka H, Kamimura T, Nakano T, Tsuruya K, Harada A: Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series                of 32 patients at single facility. Ren Fail 41:88-97,2019 

 

 

  島松和正 (Kazumasa Shimamatsu, MD, PhD)

 

1.   Koike K, Fukami K, Kawaguchi A, Shimamatsu K, Yamagishi S, Okuda S. Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodailysis patients. Int J Nephrol Renovasc Dis 9: 73-80, 2016

2.   Shimamatsu K. Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients. Clinicoecon Outcomes Res 6: 531-535, 2014

3.   Shimamatsu K, Inamasu H. A safe and easy introduction of darbepoetin-alpha in patients receiving maintenance hemodialysis and epoetin monotherapy: a “half-and-half” combination therapy. Curr Ther Res.74:5–8, 2013

4.   Shimamatsu K. Low-dose maintenance supplementation of intravenous iron chondroitin-sulfate colloid in hemodialysis patients. A 3-year follow-up. Dial Transplant 32: 595-598, 2003

5.   Shimamatsu K. Intermittent vs. continuous administration of 1α(OH)D3 on PTH suppression: Report of a case. Nephrol 8[Suppl]: A20-A21, 2003

6.   Shimamatsu K. Experience with i.v. iron chondroitin-sulphate colloid in Japanese haemodialysis patients. Nephrol Dial Transplant 13:1053, 1998

7.   Shimamatsu K. Diastolic blood pressure and progression of chronic renal failure. Nephron 55:436, 1990

8.   Sanai T., Okuda S., Onoyama K., Oochi N., Oh Y., Kobayashi K., Shimamatsu K., Fujimi S., Fujishima M. Germanium dioxide-induced nephropathy: A new type of renal disease. Nephron 54:53-60, 1990

9.    Onoyama K., Kumagai H., Takeda K., Shimamatsu K., Fujishima M. Effects of human recombinanat erythropoietin on anaemia, systemic haemodynamics and renal function in predialysis renal failure patients. Nephrol Dial Transplnt 4:966-970, 1989

10.  Shimamatsu K., Onoyama K., Fujimi S., Iseki K., Fujishima M. Does 1α(OH)D3 treatment affect blood pressure levels in maintenance hemodialysis patients? Am J Nephrol 8:471-475, 1988

11.   Shimamatsu K., Nakamoto M., Inenaga T., Wada M., Fujimi S. Hemoperfusion-hemodialysis treatment for digoxin toxicity in a uremic patient. Cur Ther Res 43:27-31, 1988

12.   Motomura K., Okuda S., Sanai T., Hirakata H., Shimamatsu K., Onoyama K., Fujishima M. Aluminium hydroxide prevents progression in experimental focal glomerular sclerosis. Nephrol Dial Transplnt 3:263-268, 1988

13.   Shimamatsu K., Onoyama K., Fujimi S., Fujishima M. Parathyroid hormone suppression by 1 alpha-hydroxycholecalciferol in chronic hemodialysis patients. Cur Ther Res 41:374-379, 1987

14.   Shimamatsu K., Fujimi S., Onoyama K., Tsuruda H., Fhijishima M. Residual renal function with different frequencies of hemodialysis treatment in end-stage renal failure patients. J Jpn Soc Dial Ther 20:105-109, 1987

15.   Okuda S., Kiyama S., Oh Y., Shimamatsu K., Oochi N., Kobayashi K., Nanishi F., Fujimi S., Onoyama K., Fujishima M. Persistent renal dysfunction induced by chronic intake of germanium-containing compounds. Cur Ther Res 41:265-275, 1987

16.   Kumagai H., Inenaga T., Shimamatsu K., Nakamoto M., Fujimi S., Harada a., Onoyama K. A case of acute poststreptococcal glomerulonephritis associated with cerebral hemorrhage. Jpn J Nephrol 29:1175-1179, 1987

17.   Kumagai H., Onoyama K., Hirakata H., Katafuchi R., Hori K., Oochi N., Tsuruda H., Inenaga T., Okuda S., Nanishi F., Shimamatsu K., Fujimi S., Fujishima M. Bradyarrhythmia induced by orally administered verapamil and propranolol in chronic hemodialysis patients. Cur Ther Res 40:1-6, 1986

18.   Shimamatsu K., Fouad-Tarazi FM. Basal inotropic state in rats with renal hypertension: Influence of coronary flow and perfusion pressure. Cardiovasc Res 20:269-274, 1986

19.   Fouad FM., Shimamatsu K., Said SI., Tarazi RC. Inotropic responsiveness in hypertensive left ventricular hypertrophy: Impaired inotropic response to glucagons and vasoactive intestinal peptide in renal hypertensive rats. J Cardiovasc Pharmacol 8:398-405, 1986

20.   Shimamatsu K., Onoyama K., Harada H., Kumagai H., Hirakata H., Miishima C., Inenaga T., Fujimi S., Fujishima M., Omae T. Effect of blood pressure on the progression rate of renal impairment in chronic glomerulonephritis. J Clin Hypertens 3:239-244, 1985

21.   Fouad FM., Shimamatsu K., Hanna MM., Khairallah PA., Tarazi RC. Impaired inotropic responses toα-adrenergic stimulation in experimental left ventricular hypertrophy. Circulation 71:1023-1028, 1985

22.   Shimamatsu K., Onoyama K., Maeda T., Ohryoji F., Fujimi s., Omae T. Massive pulmonary embolism occurring with corticosteroid and diutetics therapy in a minimal-change nephritic patient. Nephron 32:78-79, 1982

23.   Shimamatsu K., Maeda T., Harada A., Nishitani H., Onoyama K., Fujimi S., Omae T. 1-year controlled trial of 1α-hydroxycholecalciferol in patients on maintenance hemodialysis. Nephron 28:70-75, 1981

24.   Kobayashi K., Harada A., Onoyama K., Shimamatsu K., Maeda T., Fujimi S., Omae T. Idiopathic membranous glomerulonephritis associated with diabetes mellitus. Nephron 28:163-168, 1981 

25.   Iseki K., Onoyama K., Maeda T., Shimamatsu K., Harada A., Fujimi S., Omae T. Comparison of hemodynamics induced by conventional acetate hemodialysis, bicarbonate hemodialysis and ultrafiltration. Clin Nephrol 14:294-298, 1980